|
|
|
|
Vol. 62, Issue 2, 334-342, August 2002
4 Nicotinic Receptor
Subunit Results in An Alteration in Receptor Function
Institute for Behavioral Genetics, University of Colorado, Boulder,
Colorado (P.D., M.J.M., P.W., S.A.B., A.C.C.); Department of
Pharmacology, University of Colorado Health Sciences Center, Denver,
Colorado (P.D.); and Department of Pharmacology, University of
Michigan, Ann Arbor, Michigan (J.A.S.)
Nicotine-stimulated 86Rb+ efflux and
[3H]cytisine binding, both of which seem to measure the
nicotinic acetylcholine receptor, composed of
4 and
2
subunits, were assessed in eight brain regions obtained from 14 inbred
mouse strains. The potential role of a single nucleotide polymorphism
(SNP) in the nicotinic receptor
4 subunit gene (Chrna4) on nicotinic
receptor binding and function in mice was also evaluated. This SNP
leads to an alanine-to-threonine variation at amino acid position 529 of the nascent
4 subunit polypeptide. Both nicotine-stimulated
86Rb+ efflux and [3H]cytisine
binding were found to vary across brain regions and among mouse
strains. Variability in nicotine-stimulated
86Rb+ efflux was positively correlated
(r > 0.9) within each strain with the number of
[3H]cytisine binding sites. However, the number of
[3H]cytisine binding sites was not correlated with
nicotine-stimulated 86Rb+ efflux across mouse
strains. In contrast, the Chrna4 polymorphism was associated with
receptor function across mouse strains: 86Rb+
efflux was greater in seven of the eight brain regions studied in those
mouse strains that carry the Ala-529 variant of Chrna4. The Chrna4 SNP
did not seem to influence the number of [3H]cytisine
binding sites across mouse strains. These data indicate that inbred
mouse strains exhibit differences in receptor function that cannot be
attributed to variation in receptor expression but may be explained, at
least in part, by the missense polymorphism in the
4 subunit.
This article has been cited by other articles:
![]() |
K. E. Hutchison, D. L. Allen, F. M. Filbey, C. Jepson, C. Lerman, N. L. Benowitz, J. Stitzel, A. Bryan, J. McGeary, and H. M. Haughey CHRNA4 and Tobacco Dependence: From Gene Regulation to Treatment Outcome Arch Gen Psychiatry, September 1, 2007; 64(9): 1078 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Saccone, A. L. Hinrichs, N. L. Saccone, G. A. Chase, K. Konvicka, P. A.F. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. Pomerleau, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs Hum. Mol. Genet., January 1, 2007; 16(1): 36 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Butt, N. M. King, J. A. Stitzel, and A. C. Collins Interaction of the Nicotinic Cholinergic System with Ethanol Withdrawal J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 591 - 599. [Abstract] [Full Text] [PDF] |
||||